We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

196 hedge funds and large institutions have $2.31B invested in Stoke Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 27

52% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 52

9% more capital invested

Capital invested by funds: $2.13B → $2.31B (+$189M)

7% more funds holding

Funds holding: 183 → 196 (+13)

2.94% more ownership

Funds ownership: 117.28% → 120.21% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

57% less call options, than puts

Call options by funds: $3.7M | Put options by funds: $8.68M

Holders
196
Holders Change
+13
Holders Change %
+7.1%
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
43
Increased
79
Reduced
52
Closed
27
Calls
$3.7M
Puts
$8.68M
Net Calls
-$4.98M
Net Calls Change
-$22.7M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$77.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$51.2M
3
TCA
Troluce Capital Advisors
Puerto Rico
+$21.4M
4
Millennium Management
Millennium Management
New York
+$15.5M
5
Bank of America
Bank of America
North Carolina
+$11M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.8M
2
LCM
Lynx1 Capital Management
Puerto Rico
-$21M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$10.5M
4
Goldman Sachs
Goldman Sachs
New York
-$10.2M
5
SL
Siren LLC
Connecticut
-$8.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$17.7M +$11M +336,931 +163%
CS
27
Candriam SCA
Luxembourg
$16.3M +$1.81M +55,330 +12%
TCM
28
Tang Capital Management
California
$16.3M – – –
Millennium Management
29
Millennium Management
New York
$15.4M +$15.5M +472,141 New
VPM
30
Vanguard Portfolio Management
Pennsylvania
$15.1M +$15.2M +462,682 New
Charles Schwab
31
Charles Schwab
California
$14.2M +$862K +26,269 +6%
EAM
32
Erste Asset Management
Austria
$14.2M +$1.64M +50,000 +13%
Northern Trust
33
Northern Trust
Illinois
$14.1M +$933K +28,462 +7%
VFT
34
Vanguard Fiduciary Trust
Pennsylvania
$11.6M +$11.7M +356,947 New
PHP
35
Parkman Healthcare Partners
Connecticut
$11M -$3.07M -93,636 -22%
GIM
36
Granahan Investment Management
Massachusetts
$10.9M +$4.73M +144,189 +75%
Artisan Partners
37
Artisan Partners
Wisconsin
$10.3M +$10.3M +315,492 New
JP Morgan Chase
38
JP Morgan Chase
New York
$8.43M -$409K -12,457 -4%
T. Rowe Price Investment Management
39
T. Rowe Price Investment Management
Maryland
$8.17M +$8.23M +250,913 New
BC
40
Birchview Capital
Vermont
$6.84M -$1.64M -50,000 -19%
First Trust Advisors
41
First Trust Advisors
Illinois
$5.32M +$25.6K +780 +0.5%
UBS Group
42
UBS Group
Switzerland
$5.15M -$374K -11,409 -7%
Invesco
43
Invesco
Georgia
$4.89M -$3.59M -109,498 -42%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$4.67M +$85.4K +2,605 +2%
Franklin Resources
45
Franklin Resources
California
$4.65M +$347K +10,571 +8%
DCM
46
DAFNA Capital Management
California
$4.26M +$721K +22,000 +20%
Citadel Advisors
47
Citadel Advisors
Florida
$4.01M +$3.51M +107,171 +676%
SPS
48
Susquehanna Portfolio Strategies
Pennsylvania
$3.88M -$234K -7,124 -6%
GGHC
49
Gilder Gagnon Howe & Co
New York
$3.67M -$322K -9,821 -8%
N
50
Nuveen
North Carolina
$3.54M +$143K +4,356 +4%
1
2
3 4 5

STOK Hedge Fund Activity: Q1 2026 in Review

196 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2026, worth a combined $2.31B — up 8.9% from $2.13B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new STOK positions and 27 closed out — a net gain of 16 holders — while 79 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $38.8M sold.

  • 196 institutional investors held Stoke Therapeutics (STOK) as of Q1 2026, up from 183 in Q4 2025.
  • Funds reported $2.31B of Stoke Therapeutics stock for Q1 2026, up 8.9% quarter-over-quarter.
  • 43 funds opened new Stoke Therapeutics positions in Q1 2026 and 27 closed out, a net change of +16 holders.
  • The largest Stoke Therapeutics buyer in Q1 2026 was Wellington Management Group, an estimated $77.4M added.
  • The largest Stoke Therapeutics seller in Q1 2026 was Point72 Asset Management, an estimated $38.8M sold.

Based on aggregated 13F filings for Q1 2026.